Skip to main content
. 2019 Aug 15;21(4):81. doi: 10.1007/s10544-019-0412-y

Fig. 19.

Fig. 19

Typical process vs. Theranos’ product development process. Theranos moved their diagnostic platform directly from R&D stage to the market. It skipped the peer review, clinical testing and government clearance procedure